Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience

Claudia Ciaccio, Veronica Saletti, Stefano D'Arrigo, Silvia Esposito, Enrico Alfei, Isabella Moroni, Davide Tonduti, Luisa Chiapparini, Chiara Pantaleoni, Donatella Milani

Research output: Contribution to journalArticle

Abstract

Objective of the study: To give a full overview of the clinical presentation of PTEN mutations in pediatric patients and to propose a pediatric follow-up protocol. Methods: Recruitment of 16 PTEN mutated children (age 6 months-11 years) from two pediatric centers in Milan (Italy) between 2006 and 2017. All the patients underwent clinical and neurologic evaluations, cognitive and behavioral tests, and brain MRI; they are currently following an oncologic follow-up. Results: Extreme macrocephaly is present in all the patients (69% HC above +4 SD). Neuropsychiatric issues have high prevalence, with 56% of patients showing developmental delay and 25% showing autism spectrum disorder. Brain MRI reveals in 75% of the patients at least one of the following: enlarged perivascular spaces, white matter anomalies, and/or downward displacement of the cerebellar tonsils through the foramen magnum, resulting in Chiari I malformation in two patients. Vascular malformations have a prevalence of 19%, with further evidence that complex cardiovascular malformations may be related to PTEN mutations; 31% of patients present hamartomas. None of our patients have so far experienced any oncologic complication. Conclusions: We suggest to screen for PTEN mutations all children presenting macrocephaly and one of the following: neurodevelopmental issues, one of the three major brain MRI anomalies, cutaneous lesions, vascular malformations, family history positive for PTEN related malignancies; or also with macrocephaly alone when exceeding +3 SD. Basing on our cohort results and further recent studies on the condition, we recommend a follow-up protocol that includes annual clinical and dermatological examination, thyroid and abdominal US, and Fecal Occult Blood test plus neurodevelopmental evaluation, heart US (to exclude congenital heart malformations), and brain MRI (to exclude Chiari I malformation) at diagnosis.

Original languageEnglish
Article number103596
JournalEuropean Journal of Medical Genetics
Volume62
Issue number12
DOIs
Publication statusPublished - 2019

Fingerprint

Pediatrics
Mutation
Megalencephaly
Vascular Malformations
Brain
Foramen Magnum
Occult Blood
Hamartoma
Congenital Heart Defects
Palatine Tonsil
Hematologic Tests
Nervous System
Italy
Thyroid Gland
Skin
Neoplasms

Keywords

  • Chiari I malformation
  • Dysmorphology
  • Neurodevelopmental disorders
  • Pediatric oncology
  • PTEN

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. / Ciaccio, Claudia; Saletti, Veronica; D'Arrigo, Stefano; Esposito, Silvia; Alfei, Enrico; Moroni, Isabella; Tonduti, Davide; Chiapparini, Luisa; Pantaleoni, Chiara; Milani, Donatella.

In: European Journal of Medical Genetics, Vol. 62, No. 12, 103596, 2019.

Research output: Contribution to journalArticle

@article{f3012df1fb464d708e90ebe3a60df435,
title = "Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience",
abstract = "Objective of the study: To give a full overview of the clinical presentation of PTEN mutations in pediatric patients and to propose a pediatric follow-up protocol. Methods: Recruitment of 16 PTEN mutated children (age 6 months-11 years) from two pediatric centers in Milan (Italy) between 2006 and 2017. All the patients underwent clinical and neurologic evaluations, cognitive and behavioral tests, and brain MRI; they are currently following an oncologic follow-up. Results: Extreme macrocephaly is present in all the patients (69{\%} HC above +4 SD). Neuropsychiatric issues have high prevalence, with 56{\%} of patients showing developmental delay and 25{\%} showing autism spectrum disorder. Brain MRI reveals in 75{\%} of the patients at least one of the following: enlarged perivascular spaces, white matter anomalies, and/or downward displacement of the cerebellar tonsils through the foramen magnum, resulting in Chiari I malformation in two patients. Vascular malformations have a prevalence of 19{\%}, with further evidence that complex cardiovascular malformations may be related to PTEN mutations; 31{\%} of patients present hamartomas. None of our patients have so far experienced any oncologic complication. Conclusions: We suggest to screen for PTEN mutations all children presenting macrocephaly and one of the following: neurodevelopmental issues, one of the three major brain MRI anomalies, cutaneous lesions, vascular malformations, family history positive for PTEN related malignancies; or also with macrocephaly alone when exceeding +3 SD. Basing on our cohort results and further recent studies on the condition, we recommend a follow-up protocol that includes annual clinical and dermatological examination, thyroid and abdominal US, and Fecal Occult Blood test plus neurodevelopmental evaluation, heart US (to exclude congenital heart malformations), and brain MRI (to exclude Chiari I malformation) at diagnosis.",
keywords = "Chiari I malformation, Dysmorphology, Neurodevelopmental disorders, Pediatric oncology, PTEN",
author = "Claudia Ciaccio and Veronica Saletti and Stefano D'Arrigo and Silvia Esposito and Enrico Alfei and Isabella Moroni and Davide Tonduti and Luisa Chiapparini and Chiara Pantaleoni and Donatella Milani",
year = "2019",
doi = "10.1016/j.ejmg.2018.12.001",
language = "English",
volume = "62",
journal = "European Journal of Medical Genetics",
issn = "1769-7212",
publisher = "Elsevier Masson SAS",
number = "12",

}

TY - JOUR

T1 - Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience

AU - Ciaccio, Claudia

AU - Saletti, Veronica

AU - D'Arrigo, Stefano

AU - Esposito, Silvia

AU - Alfei, Enrico

AU - Moroni, Isabella

AU - Tonduti, Davide

AU - Chiapparini, Luisa

AU - Pantaleoni, Chiara

AU - Milani, Donatella

PY - 2019

Y1 - 2019

N2 - Objective of the study: To give a full overview of the clinical presentation of PTEN mutations in pediatric patients and to propose a pediatric follow-up protocol. Methods: Recruitment of 16 PTEN mutated children (age 6 months-11 years) from two pediatric centers in Milan (Italy) between 2006 and 2017. All the patients underwent clinical and neurologic evaluations, cognitive and behavioral tests, and brain MRI; they are currently following an oncologic follow-up. Results: Extreme macrocephaly is present in all the patients (69% HC above +4 SD). Neuropsychiatric issues have high prevalence, with 56% of patients showing developmental delay and 25% showing autism spectrum disorder. Brain MRI reveals in 75% of the patients at least one of the following: enlarged perivascular spaces, white matter anomalies, and/or downward displacement of the cerebellar tonsils through the foramen magnum, resulting in Chiari I malformation in two patients. Vascular malformations have a prevalence of 19%, with further evidence that complex cardiovascular malformations may be related to PTEN mutations; 31% of patients present hamartomas. None of our patients have so far experienced any oncologic complication. Conclusions: We suggest to screen for PTEN mutations all children presenting macrocephaly and one of the following: neurodevelopmental issues, one of the three major brain MRI anomalies, cutaneous lesions, vascular malformations, family history positive for PTEN related malignancies; or also with macrocephaly alone when exceeding +3 SD. Basing on our cohort results and further recent studies on the condition, we recommend a follow-up protocol that includes annual clinical and dermatological examination, thyroid and abdominal US, and Fecal Occult Blood test plus neurodevelopmental evaluation, heart US (to exclude congenital heart malformations), and brain MRI (to exclude Chiari I malformation) at diagnosis.

AB - Objective of the study: To give a full overview of the clinical presentation of PTEN mutations in pediatric patients and to propose a pediatric follow-up protocol. Methods: Recruitment of 16 PTEN mutated children (age 6 months-11 years) from two pediatric centers in Milan (Italy) between 2006 and 2017. All the patients underwent clinical and neurologic evaluations, cognitive and behavioral tests, and brain MRI; they are currently following an oncologic follow-up. Results: Extreme macrocephaly is present in all the patients (69% HC above +4 SD). Neuropsychiatric issues have high prevalence, with 56% of patients showing developmental delay and 25% showing autism spectrum disorder. Brain MRI reveals in 75% of the patients at least one of the following: enlarged perivascular spaces, white matter anomalies, and/or downward displacement of the cerebellar tonsils through the foramen magnum, resulting in Chiari I malformation in two patients. Vascular malformations have a prevalence of 19%, with further evidence that complex cardiovascular malformations may be related to PTEN mutations; 31% of patients present hamartomas. None of our patients have so far experienced any oncologic complication. Conclusions: We suggest to screen for PTEN mutations all children presenting macrocephaly and one of the following: neurodevelopmental issues, one of the three major brain MRI anomalies, cutaneous lesions, vascular malformations, family history positive for PTEN related malignancies; or also with macrocephaly alone when exceeding +3 SD. Basing on our cohort results and further recent studies on the condition, we recommend a follow-up protocol that includes annual clinical and dermatological examination, thyroid and abdominal US, and Fecal Occult Blood test plus neurodevelopmental evaluation, heart US (to exclude congenital heart malformations), and brain MRI (to exclude Chiari I malformation) at diagnosis.

KW - Chiari I malformation

KW - Dysmorphology

KW - Neurodevelopmental disorders

KW - Pediatric oncology

KW - PTEN

UR - http://www.scopus.com/inward/record.url?scp=85058174790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058174790&partnerID=8YFLogxK

U2 - 10.1016/j.ejmg.2018.12.001

DO - 10.1016/j.ejmg.2018.12.001

M3 - Article

AN - SCOPUS:85058174790

VL - 62

JO - European Journal of Medical Genetics

JF - European Journal of Medical Genetics

SN - 1769-7212

IS - 12

M1 - 103596

ER -